DK2720563T4 - Metaboliske trykeffekter af særligt udformede lipidbestanddele - Google Patents

Metaboliske trykeffekter af særligt udformede lipidbestanddele Download PDF

Info

Publication number
DK2720563T4
DK2720563T4 DK12730694.2T DK12730694T DK2720563T4 DK 2720563 T4 DK2720563 T4 DK 2720563T4 DK 12730694 T DK12730694 T DK 12730694T DK 2720563 T4 DK2720563 T4 DK 2720563T4
Authority
DK
Denmark
Prior art keywords
specially designed
lipid components
pressure effects
designed lipid
metabolic
Prior art date
Application number
DK12730694.2T
Other languages
English (en)
Other versions
DK2720563T3 (da
Inventor
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Martine Sandra Alles
Annemarie Oosting
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46397603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2720563(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK2720563T3 publication Critical patent/DK2720563T3/da
Publication of DK2720563T4 publication Critical patent/DK2720563T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
DK12730694.2T 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele DK2720563T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2011/050437 WO2012173467A1 (en) 2011-06-16 2011-06-16 Metabolic imprinting effects of specifically designed lipid component
PCT/NL2012/050428 WO2012173486A1 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Publications (2)

Publication Number Publication Date
DK2720563T3 DK2720563T3 (da) 2016-10-17
DK2720563T4 true DK2720563T4 (da) 2023-04-03

Family

ID=46397603

Family Applications (4)

Application Number Title Priority Date Filing Date
DK12730693.4T DK2720562T4 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele
DK12730694.2T DK2720563T4 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele
DK16183396.7T DK3138415T3 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele
DK16183392.6T DK3156052T3 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12730693.4T DK2720562T4 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK16183396.7T DK3138415T3 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele
DK16183392.6T DK3156052T3 (da) 2011-06-16 2012-06-18 Metaboliske trykeffekter af særligt udformede lipidbestanddele

Country Status (14)

Country Link
US (3) US20140170260A1 (da)
EP (4) EP3138415B1 (da)
CN (4) CN106262925A (da)
BR (2) BR112013032008A2 (da)
DK (4) DK2720562T4 (da)
ES (4) ES2601838T5 (da)
HR (4) HRP20161271T1 (da)
MY (2) MY165142A (da)
PH (2) PH12013502465A1 (da)
PL (4) PL3138415T3 (da)
PT (4) PT3138415T (da)
RU (2) RU2586930C2 (da)
SI (4) SI3156052T1 (da)
WO (3) WO2012173467A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
AR086993A1 (es) 2011-06-20 2014-02-05 Gen Biscuit Masa de galletita
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) * 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US20140255537A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
CN105592711A (zh) * 2013-07-30 2016-05-18 拜内梅尔克公司 用于泌乳反刍动物的饲料
EP2845490A1 (en) * 2013-09-05 2015-03-11 Loders Croklaan B.V. Fat composition for improved body fat distribution
US20160227810A1 (en) * 2013-10-17 2016-08-11 University Of Georgia Research Foundation, Inc. Structured triacylglycerols and methods for making the same
ES2693519T3 (es) * 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
WO2015067325A1 (en) * 2013-11-11 2015-05-14 N.V. Nutricia Powdered nutritional composition with large lipid globules
US20160015068A1 (en) * 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN108366986A (zh) * 2015-10-15 2018-08-03 N·V·努特里奇亚 用于促进健康生长的具有乳脂的婴儿配方物
US20210392934A1 (en) * 2016-03-10 2021-12-23 Enzymotec Ltd. Lipid compositions and uses thereof
AU2017307952A1 (en) 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
CN107049240A (zh) * 2017-01-18 2017-08-18 英华达（上海）科技有限公司 身体年龄计算方法及体脂测量系统
CN110678086B (zh) * 2017-03-29 2023-10-20 N·V·努特里奇亚 用于改善的饮食行为的婴儿配方物
WO2018178302A1 (en) * 2017-03-29 2018-10-04 N.V. Nutricia Infant formula for improved eating behaviour
CN109418396A (zh) * 2017-08-22 2019-03-05 中国农业大学 人工脂滴及其应用
CN112087956A (zh) * 2018-04-03 2020-12-15 N·V·努特里奇亚 用于预防干性皮肤的营养组合物
WO2021110916A1 (en) 2019-12-05 2021-06-10 N.V. Nutricia Infant formula with special lipid architecture for improving postnatal growth of infants born to overweight and obese mothers
BR112022010232A2 (pt) * 2019-12-05 2022-09-06 Nutricia Nv Método para melhora não terapêutica da trajetória de crescimento ou desenvolvimento corporal pós-natal em um lactente que nasce por cesariana e composição nutricional
MY208858A (en) * 2020-12-29 2025-06-04 Wilmar Shanghai Biotechnology Res & Dev Ct Co Ltd Composition for improving digestion of lipid contained in food, and use thereof
WO2022248599A1 (en) 2021-05-26 2022-12-01 N.V. Nutricia Infant formula comprising milk fat for reducing the risk of obesity in at risk infants
EP4346447A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula for improving body composition development
EP4510845B1 (en) 2022-04-20 2026-05-06 N.V. Nutricia Infant formula with special lipid architecture for reducing childhood blood pressure
WO2024073463A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Oleosome composition
US20260090551A1 (en) * 2022-09-28 2026-04-02 Cargill, Incorporated Oleosome composition
US20260090577A1 (en) * 2022-09-28 2026-04-02 Cargill, Incorporated Oleosome composition with bio-actives
CA3268653A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated SUNFLOWER OLEOSOME COMPOSITION
AU2024217119A1 (en) 2023-02-07 2025-08-07 N.V. Nutricia Nutritional composition with improved segregation resistance
WO2026033137A1 (en) 2024-08-08 2026-02-12 N.V. Nutricia Particulate nutritional composition with large lipid globules
WO2026033138A1 (en) 2024-08-09 2026-02-12 N.V. Nutricia Nutritional composition with large lipid globules and native protein
CN121176888B (zh) * 2025-11-24 2026-02-27 四川省医学科学院·四川省人民医院 一种用于辅助排便系统的粪便硬度评估方法及系统

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
DE69201651T2 (de) * 1991-01-23 1995-07-13 Unilever Nv Muttermilch-Fettersatzstoffe.
JP2761294B2 (ja) 1993-05-13 1998-06-04 ロデルス−クロクラーン エステル交換トリグリセリドブレンド由来のヒト母乳脂肪代用品
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
RU2413430C2 (ru) * 2005-04-27 2011-03-10 Энзимотек Лтд. Композиция жировой основы (варианты) и способ ее получения (варианты), композиция заменителя жира женского молока и способ ее получения (варианты), смесь для детского питания
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ES2537080T3 (es) 2005-12-23 2015-06-02 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas y manganeso y/o molibdeno para mejorar la composición de membranas celulares
DE102007022694A1 (de) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
US8226737B2 (en) 2008-07-03 2012-07-24 3M Innovative Properties Company Fixed abrasive particles and articles made therefrom
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat

Also Published As

Publication number Publication date
DK3138415T3 (da) 2023-01-30
WO2012173467A1 (en) 2012-12-20
HRP20161272T4 (hr) 2023-03-31
MY163520A (en) 2017-09-15
SI2720563T1 (sl) 2017-03-31
PL2720563T5 (pl) 2023-04-24
WO2012173485A1 (en) 2012-12-20
RU2014101160A (ru) 2015-07-27
EP3138415B1 (en) 2022-12-14
HRP20161271T1 (hr) 2016-12-16
HRP20230159T1 (hr) 2023-03-31
ES2601838T3 (es) 2017-02-16
CN103763941A (zh) 2014-04-30
US20140170260A1 (en) 2014-06-19
PT2720563T (pt) 2016-11-02
PT2720562T (pt) 2016-11-02
EP2720563B1 (en) 2016-08-10
PT3156052T (pt) 2023-01-27
ES2601302T3 (es) 2017-02-14
ES2939808T3 (es) 2023-04-27
ES2939943T3 (es) 2023-04-28
HRP20161272T1 (hr) 2017-02-10
PL2720562T3 (pl) 2017-02-28
EP2720563A1 (en) 2014-04-23
PH12013502465A1 (en) 2014-01-20
MY165142A (en) 2018-02-28
ES2601302T5 (es) 2023-06-19
BR112013032008A2 (pt) 2016-08-09
RU2014101211A (ru) 2015-07-27
CN103687500B (zh) 2016-08-31
EP3156052B1 (en) 2022-12-14
EP2720562A1 (en) 2014-04-23
EP2720562B2 (en) 2023-02-22
US20160081963A1 (en) 2016-03-24
RU2586930C2 (ru) 2016-06-10
EP2720563B2 (en) 2023-02-22
PT3138415T (pt) 2023-01-23
RU2591716C2 (ru) 2016-07-20
US20140187480A1 (en) 2014-07-03
DK2720563T3 (da) 2016-10-17
PL3138415T3 (pl) 2023-04-03
WO2012173486A1 (en) 2012-12-20
SI3138415T1 (sl) 2023-04-28
SI2720563T2 (sl) 2023-04-28
US9649286B2 (en) 2017-05-16
PL2720562T5 (pl) 2023-04-24
HRP20230160T1 (hr) 2023-03-31
DK2720562T4 (da) 2023-04-03
DK2720562T3 (da) 2016-10-24
CN106262925A (zh) 2017-01-04
ES2601838T5 (es) 2023-06-19
CN108041605A (zh) 2018-05-18
SI3156052T1 (sl) 2023-03-31
US9532966B2 (en) 2017-01-03
SI2720562T1 (sl) 2017-03-31
EP3138415A1 (en) 2017-03-08
EP2720562B1 (en) 2016-08-10
CN103687500A (zh) 2014-03-26
EP3156052A1 (en) 2017-04-19
PH12013502466A1 (en) 2014-01-20
DK3156052T3 (da) 2023-01-30
PL2720563T3 (pl) 2017-02-28
PL3156052T3 (pl) 2023-05-02
BR112013031916B1 (pt) 2020-09-01
BR112013031916A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
DK2720562T4 (da) Metaboliske trykeffekter af særligt udformede lipidbestanddele
DK2724135T3 (da) Dynamisk tredimensional billeddannelse af øregange
EP2749912A4 (en) ANTI GLOSS FOIL
DK3336082T3 (da) Spaltelige lipider
DK3235812T3 (da) Deutererede derivater af ivacaftor
EP2781569A4 (en) BONDING FILM
EP2767566A4 (en) BONDING FILM
BR112013033633A2 (pt) método de formação de um laminado elástico
UY4117Q (es) Carcasa reloj
KR101574867B9 (ko) 복합 필름
EP2693175A4 (en) MORE HEAD SCALE
PL3442228T3 (pl) Sposób dekodowania obrazów
DK2733803T4 (da) Sektion af kabelbakke
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
EP2665603A4 (en) MULTILAYER FOIL
EP2754555A4 (en) COATED FOIL
EP2672239A4 (en) MORE HEAD SCALE
IL229958B (en) Improvements to pumps and components therefor
UA23645S (uk) Комплект меблів
UA23289S (uk) Комплект етикеток
UA23972S (uk) Комплект етикеток
UA23337S (uk) Комплект етикеток
UA23160S (uk) Комплект етикеток
UA22783S (uk) Комплект етикеток
UA22757S (uk) Комплект етикеток